BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16774755)

  • 1. Homocysteine and coronary heart disease risk in the PRIME study.
    Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
    Atherosclerosis; 2007 Mar; 191(1):90-7. PubMed ID: 16774755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
    Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
    Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
    Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
    Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):79-84. PubMed ID: 17301631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
    Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
    Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study.
    Canoui-Poitrine F; Luc G; Juhan-Vague I; Morange PE; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Ducimetiere P; Empana JP;
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):550-5. PubMed ID: 19629011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort.
    Bataille V; Perret B; Dallongeville J; Arveiler D; Yarnell J; Ducimetière P; Ferrières J
    Diabetes Metab; 2006 Nov; 32(5 Pt 1):475-9. PubMed ID: 17110903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
    Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
    Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity and coronary event incidence in Northern Ireland and France: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Wagner A; Simon C; Evans A; Ferrières J; Montaye M; Ducimetière P; Arveiler D
    Circulation; 2002 May; 105(19):2247-52. PubMed ID: 12010905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism.
    Mehlig K; Leander K; de Faire U; Nyberg F; Berg C; Rosengren A; Björck L; Zetterberg H; Blennow K; Tognon G; Torén K; Strandhagen E; Lissner L; Thelle D
    Heart; 2013 Dec; 99(23):1761-5. PubMed ID: 24014284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Juhan-Vague I; Ferrieres J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetiere P;
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1255-61. PubMed ID: 12775578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
    Empana JP; Sykes DH; Luc G; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Bingham A; Montaye M; Ruidavets JB; Haas B; Evans A; Jouven X; Ducimetiere P;
    Circulation; 2005 May; 111(18):2299-305. PubMed ID: 15867179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Haim M; Tanne D; Goldbourt U; Doolman R; Boyko V; Brunner D; Sela BA; Behar S
    Cardiology; 2007; 107(1):52-6. PubMed ID: 16763372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of risk factors for coronary heart disease--the Hordaland Homocysteine study.
    Igland J; Vollset SE; Nygård OK; Gjessing HK; Ueland PM; Tell GS
    Scand Cardiovasc J; 2012 Dec; 46(6):316-23. PubMed ID: 22881391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
    Shai I; Pischon T; Hu FB; Ascherio A; Rifai N; Rimm EB
    Obesity (Silver Spring); 2006 Nov; 14(11):2099-106. PubMed ID: 17135628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum homocysteine, vitamin B12, folate and Thai coronary artery disease patients.
    Leowattana W; Mahanonda N; Bhuripunyo K; Pokum S
    J Med Assoc Thai; 2000 May; 83(5):536-42. PubMed ID: 10863900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
    Peng HY; Man CF; Xu J; Fan Y
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):78-86. PubMed ID: 25559959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasma homocysteine levels and coronary artery disease: a population-based study in northern Greece.
    Boufidou AI; Makedou AD; Adamidis DN; Karvounis HI; Gourassas JT; Kesidis HT; Makedou KG; Papadopoulos CE; Parharidis GE; Louridas GE
    Curr Med Res Opin; 2004; 20(2):175-80. PubMed ID: 15006011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.